Drugs / Standard Trivalent Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01666782 Comparator | Aug 2012 → Jun 2015 | cancer, influenza | Saad Jamshed MD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Standard Trivalent Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01666782 ↗ |
| Modality | Vaccine | “standard-dose influenza vaccine” NCT01666782 ↗ |